Stat Surgical Supply

03/30/2026

⚠️ Important Update for Surgical Teams

A recall affecting robotic surgery stapler reloads is prompting hospitals and surgical centers to review inventory immediately.

The concern involves potential stapling failures, which can lead to serious complications during procedures.

Because these devices are essential in many surgeries, teams must:
✔ Check and quarantine affected products
✔ Confirm alternative supplies
✔ Adjust surgical planning if needed

This highlights how even small components can have a big impact on patient safety and surgical operations.

https://www.statsurgicalsupply.com/news/intuitive-surgical-stapler-reload-recall-forces-immediate-robotic-or-inventory-review

03/26/2026

Big changes are coming to the healthcare landscape.

The proposed Sutter Health and Allina Health combination could create a massive multi-state system focused on expanding ambulatory and outpatient care.

What does that mean?
More surgeries moving out of hospitals and into efficient outpatient settings — changing how care is delivered and how medical supplies are managed.

For healthcare providers and suppliers, this shift is a big deal.

👉 Read the full story to understand what this means for the future of surgical care.

https://www.statsurgicalsupply.com/news/sutter-allina-deal-signals-a-larger-shift-toward-ambulatory-expansion-in-the-u-s-surgical-market

One of the most consequential strategic developments for the U.S. surgical supply chain was the proposed combination of Sutter Health and Allina Health, a trans...

03/24/2026

The FDA has introduced a new adverse event look-up tool linked to AEMS, a new platform aimed at improving how safety reports are accessed and monitored.

This could help healthcare organizations, manufacturers, and researchers identify safety signals more quickly and respond more effectively.

Read the full article here: https://www.statsurgicalsupply.com/news/fda-launches-new-adverse-event-look-up-tool-introducing-aems-as-a-new-unified-safety-monitoring-platform

03/18/2026

The FDA is taking steps to ease certain biosimilar testing requirements, signaling a push toward faster approvals and lower development costs.

This could help more biosimilar products reach the market, increasing competition in high-cost biologic drug categories and potentially improving affordability across the healthcare system.

Read the full article here: https://www.statsurgicalsupply.com/news/fda-moves-to-ease-biosimilar-testing-rules-signaling-faster-approvals-and-lower-development-costs

The U.S. Food and Drug Administration is moving to simplify parts of the biosimilar approval process, a regulatory shift that could lower development costs, spe...

03/16/2026

Philips has announced that the FDA cleared SmartHeart, an AI-powered cardiac MRI planning system designed to make complex heart imaging easier and more consistent.

Cardiac MRI is one of the most advanced tools for evaluating the heart, but it often requires highly specialized setup and operator experience. According to Philips, SmartHeart helps automate the planning process, which could improve workflow, reduce exam complexity, and support broader access to advanced cardiac imaging.

Read the full article here: https://www.statsurgicalsupply.com/news/ai-powered-cardiac-mri-planning-system-receives-fda-clearance-asiming-to-simplify-complex-heart-imaging

03/12/2026

⚠️ Wound Care Recall Alert

The FDA has confirmed a recall affecting certain MediHoney wound products and CVS wound gel manufactured by Integra LifeSciences due to potential sterile barrier issues.

Healthcare providers are advised to:
• Identify and quarantine affected inventory
• Stop using impacted products
• Ensure substitute wound-care supplies are available

For hospitals and wound-care centers, this recall highlights the importance of strong inventory tracking and rapid response to safety alerts.

https://www.statsurgicalsupply.com/news/fda-confirms-integra-medihoney-and-cvs-wound-product-recall-extending-pressure-on-u-s-wound-care-supply-chains

One of the clearest U.S. device-safety stories from the week of March 2 to March 9, 2026 was the FDA’s March 6 classification and posting of a confirmed recall ...

03/09/2026

⚠️ Important Medical Device Recall Notice

Certain Olympus high-flow laparoscopic insufflation units have been recalled following an FDA Class I designation due to a potential risk of excessive pressure delivery during minimally invasive procedures.

For hospitals and ambulatory surgery centers, this means reviewing equipment inventory, removing affected units from service, and ensuring backup insufflation systems are available to maintain surgical scheduling.

Staying informed about device recalls helps protect both patient safety and surgical workflow continuity.

03/04/2026

A new study presented at the American Academy of Orthopaedic Surgeons meeting suggests that prior authorization requirements may delay elective spine surgery without actually reducing healthcare costs.

Researchers found that most initially denied requests were eventually approved, but the appeals process created delays that kept patients waiting longer for needed surgery.

For hospitals and surgical teams, these delays can also disrupt operating room schedules, supply planning, and patient recovery timelines.

Learn what this means for healthcare providers and patients.
https://www.statsurgicalsupply.com/news/study-presented-at-aaos-finds-prior-authorization-delays-elective-spine-surgery-without-reducing-costs

A new study presented at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) reports that prior authorization (PA) requirements for electi...

03/02/2026

⚠️ Important Recall Notice for Healthcare Facilities

The FDA has posted a recall for Medline Sterile Saline Wound Wash due to sterility concerns affecting all lots nationwide.

Because this product is commonly stocked across ORs, clinics, EDs, and outpatient centers, healthcare teams are being urged to review inventory immediately and quarantine affected items.

Even everyday medical supplies require strong recall controls to keep patients safe.

👉 Read the full : https://www.statsurgicalsupply.com/news/medline-sterile-saline-wound-was-recall-forces-or-and-asc-teams-to-re-check-routine-irrigation-stock-and-tighten-recall-controls

02/25/2026

Important update for surgical teams and healthcare supply leaders:

Recent FDA recall postings affecting insufflation equipment, robotic surgery systems, and endoscopic accessories are a reminder that surgical throughput depends heavily on device reliability and rapid response protocols.

Hospitals should stay alert, review inventory traceability, and ensure backup equipment plans are in place.

https://www.statsurgicalsupply.com/news/17-recall-wave-hits-minimally-invasive-surgery-olympus-insufflation-pull-da-vinci-5-correction-raise-or-readiness-stakes

Between February 18 and February 20, 2026, FDA recall postings highlighted a cluster of issues that sit directly in the workflow “hot zone” for minimally invasi...

02/23/2026

Food safety policy may be entering a new phase.

Growing scrutiny around the FDA’s “Generally Recognized as Safe” (GRAS) pathway is putting ultra-processed foods and ingredient oversight at the center of national health discussions. Possible changes could impact labeling transparency, compliance requirements, and consumer trust.

This is a conversation worth following closely.

👉 Read the full analysis to understand what this could mean for healthcare, industry, and consumers.

https://www.statsurgicalsupply.com/news/kennedy-targets-fda-s-gras-loophole-in-crackdown-on-ultra-processed-foods

A new federal health policy debate is intensifying after Robert F. Kennedy Jr. signaled plans to scrutinize the FDA’s long-standing “Generally Recognized as Saf...

02/18/2026

New FDA labeling changes for menopausal hormone therapy could reshape conversations around menopause treatment.

The agency has eased certain boxed warnings after reviewing newer scientific data, signaling a more nuanced approach to risk communication in women’s health. Safety information remains, but guidance now reflects updated evidence and individualized care considerations.

This shift may influence clinical decisions, patient education, and pharmaceutical market dynamics in the years ahead.

https://www.statsurgicalsupply.com/news/fda-approves-labeling-changes-for-menopausal-hormone-therapy-easing-decades-old-boxed-warnings

On February 12, 2026, the U.S. Food and Drug Administration (FDA) approved significant labeling updates for several menopausal hormone therapy (MHT) products, r...